A Safety and Efficacy Study on ULTRASE MT20 in Patients With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

This study has been completed.

Study NCT00408317 Information provided by Axcan Pharma

First Received: December 4, 2006 Last Updated: August 7, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2007
Estimated Primary Completion Date:	No date given